RNA, long overlooked in the research world, is having its moment. The pandemic provided the rocket fuel, because mRNA vaccines essentially saved our way of life. Talk of RNA-based treatments and trials is suddenly commonplace.

It's all the talk in medicine. After decades at the forefront of RNA discovery, Rochester researchers are helping to write the next chapter

Host John Foxe, PhD sits down with Lynne Maquat, PhD to explore groundbreaking research in mRNA decay and other topics

Lynne E. Maquat, Ph.D., receives 2024 Dr. Paul Janssen Award for Biomedical Research for her fundamental discoveries about RNA decay

Lynne E. Maquat, PhD, receives the distinguished 2024 Albany Medical Center Prize in Medicine and Biomedical Research

The joint venture between the University of Rochester and University at Albany will drive economic development through research and training

Joint Venture Will Drive Economic Development Through Research, Partnerships with Industry

Lynne E. Maquat, PhD, at the University of Rochester, has been awarded the 2023 Gruber Genetics Prize for her discovery of NMD in humans

University of Rochester scientists reveal how the enzyme AKT and the quality control pathway NMD interact in fragile X syndrome

Lynne E. Maquat, PhD, was honored with the 2021 Wolf Prize in Medicine for “fundamental discoveries in RNA biology"

Study shows that many abnormalities in fragile X syndrome cells are related to glitches with one of the body’s major quality control systems